NCT01159067 2019-06-18Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron OverloadCity of Hope Medical CenterPhase 2 Terminated1 enrolled 4 charts
NCT01273766 2018-09-07Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic MalignanciesWake Forest University Health SciencesPhase 2 Completed16 enrolled 10 charts